• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Jim Cramer: Health Care Stocks, the Election and the Perfect Setup

Right now, the market is furiously trying to price in a Blue Wave, and the health care sector is getting clobbered. But here's how I think things play out.
By JIM CRAMER
Oct 29, 2020 | 06:52 AM EDT
Stocks quotes in this article: UNH, MRK, LLY, DXCM, ABT

Something's happening here and what it is is exactly clear. For what it's worth -- thanks Buffalo Springfield -- let me spell it out.

Right now the market is furiously trying to price in a Blue Wave, a total landslide, and the area that's perceived as most vulnerable, the health care sector, is getting socked with sellers who, at this point, don't even care what price they get.

As usual, the common stock institutions are bailing while the hedge funds are using various ETFs to knock stocks down. Why not? The creators of these pieces of paper, who sell them as a way for individuals to avoid what they call single-stock risk, know that they are perfect for short-sellers to annihilate a group. It's another reason why I detest the come-ons about ETF products. Why not just market them for what they are really worth: a quick way to get short a group.

I only mention it because the waves of selling are so intense that they are overwhelming where the buyers live, so to speak, selling right through prices they would get otherwise. That's machine selling for certain.

And that's where the opportunity comes in. If you go into the mindset of the short-seller here it actually is much more instructive than trying to calculate how to handle a fearful long seller. That's right, the long onlys want to get out while the getting is still good.

What the shorts are betting is that come election day the Democrats will be so powerful that you are going to start hearing about socialist medicine, that the most vociferous Dems will be saying it is time for the government to negotiate price with the drug companies as is done around the rest of the world.

Others will suggest that the managed care companies should make much less money or should actually be dealt with as profiteers, something that UnitedHealth (UNH) actually brought up last year as a possibility.

Are these fears mindless and groundless?

Who the heck knows? The standard bearer, Vice President Biden, was pretty much the only candidate against the so-called single-payer option. He seemed happy with a tweaked status quo that would enlarge Obamacare and have competing insurers all over the place to keep prices down. His running mate was much more harsh and if she were president the shorts would be well-advised to stay short.

But she isn't.

So here's how I think things play out. If we get the Blue Wave then we come in Wednesday and we can expect to see the managed care stocks down about 10% and the drug stocks down about 5-6%. It's harder for them to go lower because of their bountiful yields.

This wholesale selling and shorting will be knee jerk and if you look at where the stocks have come from, a move that can only be described as total panic.

What have I taught for years?

You have to buy panic not sell into it.

I think by Thursday midday the selling will abate. Then you can pick among your favorites. Merck (MRK) reported an excellent quarter. I liked Lilly (LLY) with a stock that was clobbered because of a drug it made that didn't have the needed efficacy against Covid in the hospital.

UnitedHealth reported an incredible quarter and it's now down big. Anything below $290 could be a gift.

Finally, consider DexCom (DXCM) . It's got the best glucose monitor. But if you follow the thinking laid out here, you will believe that Medicare will only pay for the cheaper Abbott (ABT) offering. The decline in the stock of DexCom has been severe, the work of longs trying, and failing, to beat shorts out of the stock.

What a perfect setup.

I know some might say if you can't beat the shorts, join them. I get that.

There's only one problem. You don't get a Blue Wave, or, if Trump pulls off a win, you will have your lungs ripped out. I prefer to keep mine intact.

(Abbott Labs is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells ABT? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer manages as a charitable trust, is long ABT.

TAGS: Short-selling | Investing | Markets | Politics | Stocks | Trading | Healthcare | U.S. Equity |

More from Stocks

The Markets Also Rise Quickly

James "Rev Shark" DePorre
Mar 1, 2021 4:22 PM EST

Fear of missing out permeated the day as the indexes bounced back.

BlackBerry's Calling

Mark Sebastian
Mar 1, 2021 3:27 PM EST

Here's a play in the stock and why I think it will dial back down.

NantKwest's Charts Are Extended When Compared to the Popular Moving Averages

Bruce Kamich
Mar 1, 2021 3:15 PM EST

Let's stand aside for now and see how things unfold.

The Battle Over Cannabis Operator Verano Holdings' Stock

Debra Borchardt
Mar 1, 2021 2:00 PM EST

Sol Global and MMCap are fighting in court over who owns or owes what of the company's shares.

Is Chevron Finally Ready to Make an Upside Breakout?

Bruce Kamich
Mar 1, 2021 1:44 PM EST

Let's check out some charts on the energy giant.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 06:05 PM EST PAUL PRICE

    Michael's (MIK) up on take-over rumors

    The NYT says talks are underway regarding a buyo...
  • 08:09 AM EST GARY BERMAN

    Monday Morning Fibocall for 3/1/2021

    Always a good idea to know where our bounce zones ...
  • 11:51 AM EST REAL MONEY

    Watch Bob Lang and Doug Kass Discuss Short-Selling!

    Bob Lang and Doug Kass with an engaging and educat...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login